Pressure BioSciences, Inc. (PBIO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 22.67 Million USD | 11.1% |
| 2022 | 20.52 Million USD | 41.46% |
| 2021 | 14.5 Million USD | 51.51% |
| 2020 | 9.57 Million USD | 20.84% |
| 2019 | 7.92 Million USD | 61.7% |
| 2018 | 4.9 Million USD | -62.55% |
| 2017 | 13.08 Million USD | 143.53% |
| 2016 | 5.37 Million USD | 1621.32% |
| 2015 | 312.18 Thousand USD | -48.91% |
| 2014 | 611.04 Thousand USD | 38.7% |
| 2013 | 440.55 Thousand USD | -52.96% |
| 2012 | 936.54 Thousand USD | 190.73% |
| 2011 | 322.13 Thousand USD | 158.27% |
| 2010 | -552.84 Thousand USD | 65.66% |
| 2009 | -1.6 Million USD | -85.41% |
| 2008 | -868.2 Thousand USD | 83.99% |
| 2007 | -5.42 Million USD | -1.67% |
| 2006 | -5.33 Million USD | 16.85% |
| 2005 | -6.41 Million USD | 69.73% |
| 2004 | -21.2 Million USD | -1656.33% |
| 2003 | 1.36 Million USD | -5.53% |
| 2002 | 1.44 Million USD | 486.6% |
| 2001 | -373.02 Thousand USD | -104.01% |
| 2000 | 9.29 Million USD | 36.72% |
| 1999 | 6.8 Million USD | 74.36% |
| 1998 | 3.9 Million USD | 240.29% |
| 1997 | -2.78 Million USD | 65.47% |
| 1996 | -8.05 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 32.09 Million USD | 13.82% |
| 2023 Q4 | 23.8 Million USD | 28.56% |
| 2023 FY | 23.8 Million USD | 15.98% |
| 2023 Q1 | 19.63 Million USD | -4.32% |
| 2023 Q2 | 19.38 Million USD | -1.31% |
| 2023 Q3 | 18.51 Million USD | -4.46% |
| 2022 Q3 | 19.06 Million USD | 6.13% |
| 2022 Q4 | 20.52 Million USD | 7.68% |
| 2022 FY | 20.52 Million USD | 41.46% |
| 2022 Q1 | 16.19 Million USD | 11.63% |
| 2022 Q2 | 17.96 Million USD | 10.89% |
| 2021 Q2 | 13.12 Million USD | 8.24% |
| 2021 Q3 | 12.9 Million USD | -1.7% |
| 2021 Q1 | 12.12 Million USD | 26.64% |
| 2021 FY | 14.5 Million USD | 51.51% |
| 2021 Q4 | 14.5 Million USD | 12.43% |
| 2020 Q3 | 8.53 Million USD | 1.45% |
| 2020 FY | 9.57 Million USD | 20.84% |
| 2020 Q1 | 8.65 Million USD | 9.15% |
| 2020 Q2 | 8.41 Million USD | -2.69% |
| 2020 Q4 | 9.57 Million USD | 12.15% |
| 2019 Q4 | 7.92 Million USD | 17.7% |
| 2019 Q1 | 5.31 Million USD | 8.47% |
| 2019 Q2 | 5.94 Million USD | 11.88% |
| 2019 Q3 | 6.73 Million USD | 13.21% |
| 2019 FY | 7.92 Million USD | 61.7% |
| 2018 FY | 4.9 Million USD | -62.55% |
| 2018 Q4 | 4.9 Million USD | 14.0% |
| 2018 Q3 | 4.29 Million USD | 10.05% |
| 2018 Q1 | 14.58 Million USD | 11.42% |
| 2018 Q2 | 3.9 Million USD | -73.21% |
| 2017 Q2 | 9.48 Million USD | 29.06% |
| 2017 Q1 | 7.34 Million USD | 36.76% |
| 2017 FY | 13.08 Million USD | 143.53% |
| 2017 Q4 | 13.08 Million USD | 12.43% |
| 2017 Q3 | 11.64 Million USD | 22.72% |
| 2016 Q3 | 3.94 Million USD | 55.02% |
| 2016 Q2 | 2.54 Million USD | 103.09% |
| 2016 Q4 | 5.37 Million USD | 36.26% |
| 2016 Q1 | 1.25 Million USD | 301.26% |
| 2016 FY | 5.37 Million USD | 1621.32% |
| 2015 Q4 | 312.18 Thousand USD | -64.46% |
| 2015 Q3 | 878.3 Thousand USD | -50.82% |
| 2015 Q2 | 1.78 Million USD | 76.16% |
| 2015 Q1 | 1.01 Million USD | 65.92% |
| 2015 FY | 312.18 Thousand USD | -48.91% |
| 2014 Q1 | -201.51 Thousand USD | -145.74% |
| 2014 Q3 | 518.94 Thousand USD | 8.49% |
| 2014 FY | 611.04 Thousand USD | 38.7% |
| 2014 Q2 | 478.31 Thousand USD | 337.36% |
| 2014 Q4 | 611.04 Thousand USD | 17.75% |
| 2013 Q4 | 440.55 Thousand USD | -5.63% |
| 2013 Q2 | 67.67 Thousand USD | 172.83% |
| 2013 Q1 | -92.91 Thousand USD | -109.92% |
| 2013 Q3 | 466.83 Thousand USD | 589.87% |
| 2013 FY | 440.55 Thousand USD | -52.96% |
| 2012 Q2 | 142.22 Thousand USD | -25.4% |
| 2012 Q3 | 466.86 Thousand USD | 228.26% |
| 2012 Q4 | 936.54 Thousand USD | 100.6% |
| 2012 FY | 936.54 Thousand USD | 190.73% |
| 2012 Q1 | 190.64 Thousand USD | -40.82% |
| 2011 Q2 | -234.41 Thousand USD | -188.66% |
| 2011 FY | 322.13 Thousand USD | 158.27% |
| 2011 Q4 | 322.13 Thousand USD | 50910.25% |
| 2011 Q3 | -634.00 USD | 99.73% |
| 2011 Q1 | -81.2 Thousand USD | 85.31% |
| 2010 Q1 | -1.61 Million USD | -0.49% |
| 2010 FY | -552.84 Thousand USD | 65.66% |
| 2010 Q4 | -552.84 Thousand USD | 41.72% |
| 2010 Q3 | -948.55 Thousand USD | 43.45% |
| 2010 Q2 | -1.67 Million USD | -3.69% |
| 2009 Q4 | -1.6 Million USD | -17.08% |
| 2009 FY | -1.6 Million USD | -85.41% |
| 2009 Q1 | -2.13 Million USD | -146.33% |
| 2009 Q2 | -1.48 Million USD | 30.38% |
| 2009 Q3 | -1.37 Million USD | 7.66% |
| 2008 Q3 | -1.95 Million USD | 31.14% |
| 2008 Q2 | -2.83 Million USD | 31.62% |
| 2008 Q4 | -868.2 Thousand USD | 55.54% |
| 2008 FY | -868.2 Thousand USD | 83.99% |
| 2008 Q1 | -4.14 Million USD | 23.55% |
| 2007 Q4 | -5.42 Million USD | 9.67% |
| 2007 FY | -5.42 Million USD | -1.67% |
| 2007 Q3 | -6 Million USD | 11.73% |
| 2007 Q2 | -6.8 Million USD | -40.67% |
| 2007 Q1 | -4.83 Million USD | 9.35% |
| 2006 Q1 | -7.73 Million USD | -20.5% |
| 2006 Q2 | -6.8 Million USD | 11.96% |
| 2006 Q4 | -5.33 Million USD | 8.81% |
| 2006 FY | -5.33 Million USD | 16.85% |
| 2006 Q3 | -5.85 Million USD | 14.06% |
| 2005 Q1 | -4.76 Million USD | 77.54% |
| 2005 FY | -6.41 Million USD | 69.73% |
| 2005 Q4 | -6.41 Million USD | -5.36% |
| 2005 Q3 | -6.09 Million USD | -45.79% |
| 2005 Q2 | -4.17 Million USD | 12.27% |
| 2004 Q2 | 97.91 Thousand USD | -93.67% |
| 2004 FY | -21.2 Million USD | -1656.33% |
| 2004 Q4 | -21.2 Million USD | 17.17% |
| 2004 Q3 | -25.59 Million USD | -26240.9% |
| 2004 Q1 | 1.54 Million USD | 13.51% |
| 2003 Q4 | 1.36 Million USD | 25.11% |
| 2003 Q1 | 780.21 Thousand USD | -45.9% |
| 2003 Q2 | 1.64 Million USD | 111.05% |
| 2003 Q3 | 1.08 Million USD | -33.87% |
| 2003 FY | 1.36 Million USD | -5.53% |
| 2002 Q4 | 1.44 Million USD | 286.17% |
| 2002 Q1 | -616.04 Thousand USD | -65.15% |
| 2002 FY | 1.44 Million USD | 486.6% |
| 2002 Q2 | 283.14 Thousand USD | 145.96% |
| 2002 Q3 | 373.43 Thousand USD | 31.89% |
| 2001 Q2 | 596.03 Thousand USD | 221.86% |
| 2001 Q1 | -489.11 Thousand USD | -105.26% |
| 2001 FY | -373.02 Thousand USD | -104.01% |
| 2001 Q4 | -373.02 Thousand USD | -134.32% |
| 2001 Q3 | 1.08 Million USD | 82.34% |
| 2000 Q3 | 8.38 Million USD | 2.64% |
| 2000 Q1 | 8.15 Million USD | 19.93% |
| 2000 FY | 9.29 Million USD | 36.72% |
| 2000 Q4 | 9.29 Million USD | 10.84% |
| 2000 Q2 | 8.17 Million USD | 0.2% |
| 1999 Q2 | 5.3 Million USD | 1.92% |
| 1999 FY | 6.8 Million USD | 74.36% |
| 1999 Q1 | 5.2 Million USD | 33.33% |
| 1999 Q3 | 6 Million USD | 13.21% |
| 1999 Q4 | 6.8 Million USD | 13.33% |
| 1998 Q2 | 400 Thousand USD | 167.8% |
| 1998 FY | 3.9 Million USD | 240.29% |
| 1998 Q1 | -590 Thousand USD | 78.62% |
| 1998 Q4 | 3.9 Million USD | 200.0% |
| 1998 Q3 | 1.3 Million USD | 225.0% |
| 1997 Q4 | -2.76 Million USD | -28.97% |
| 1997 FY | -2.78 Million USD | 65.47% |
| 1997 Q3 | -2.14 Million USD | 62.78% |
| 1997 Q2 | -5.75 Million USD | -150.0% |
| 1997 Q1 | -2.3 Million USD | 71.57% |
| 1996 FY | -8.05 Million USD | 0.0% |
| 1996 Q4 | -8.09 Million USD | -307.44% |
| 1996 Q3 | 3.9 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | -52.949% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -10369.183% |
| Polarean Imaging plc | -5.94 Million USD | 481.35% |
| Avitar, Inc. | 5.17 Million USD | -338.53% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 3842.094% |
| AVITA Medical, Inc. | -26.23 Million USD | 186.449% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 324058.4% |
| Össur hf. | 395.08 Million USD | 94.26% |
| Zecotek Photonics Inc. | 2.76 Million USD | -720.905% |
| QHSLab, Inc. | 1.72 Million USD | -1210.837% |
| Wellstar International, Inc. | 51.36 Million USD | 55.853% |
| Össur hf. | 395.08 Million USD | 94.26% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 591.147% |
| Escalon Medical Corp. | 315.68 Thousand USD | -7083.432% |
| Aurora Spine Corporation | 1.9 Million USD | -1088.742% |
| BrainsWay Ltd. | -10.32 Million USD | 319.739% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -839.0% |
| Hamilton Thorne Ltd. | 18.12 Million USD | -25.108% |
| Vivos Inc. | -1.59 Million USD | 1524.183% |
| MicroPort Scientific Corporation | 673.58 Million USD | 96.633% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -4553.304% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 4291.807% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -3442.205% |
| Nanomix Corporation | 11.38 Million USD | -99.111% |
| Theraclion SA | -5.86 Million EUR | 486.682% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -468.992% |
| Positron Corporation | 1.68 Million USD | -1244.321% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -1307.779% |
| Lombard Medical, Inc. | 11.49 Million USD | -97.278% |
| ALR Technologies Inc. | 19.14 Million USD | -18.429% |
| Stratec SE | 119.12 Million USD | 80.964% |
| Vycor Medical, Inc. | 1.05 Million USD | -2053.658% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -41134.818% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -24233.206% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 264.478% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 24.778% |
| VMS Rehab Systems, Inc. | 133.52 USD | -16983938.346% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -1445.815% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -3494.295% |
| Odyssey Group International, Inc. | 2.1 Million USD | -975.868% |
| United American Healthcare Corporation | -9.32 Million USD | 343.134% |
| ECGI Holdings, Inc. | 3.17 Million USD | -615.085% |
| Capital Group Holdings, Inc. | -3508.00 USD | 646539.225% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -8535.009% |
| Urologix, Inc. | 4.61 Million USD | -391.378% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | -438.722% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -580.739% |
| SS Innovations International, Inc. | 1.18 Million USD | -1813.121% |
| Qualis Innovations, Inc. | 6671.00 USD | -339835.362% |
| Smith & Nephew plc | 2.77 Billion USD | 99.184% |
| NIOX Group Plc | -23.93 Million USD | 194.755% |
| Fuse Medical, Inc. | 1.75 Million USD | -1191.777% |
| Broncus Holding Corporation | -81.42 Million USD | 127.85% |
| Brain Scientific Inc. | 2.11 Million USD | -971.812% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -57227.623% |